Vaccinia detection in body fluids and anti-vaccinia immune response
MPM, TNBC, NSCLC, pleural fluid).-Insufficient
NON-SMALL CELL LUNG CANCER, VIRUS, SQUAMOUS CELL CARCINOMA, TRIPLE NEGATIVE BREAST CANCER, VACCINIA, VACCINIA, ADENOCARCINOMA, MALIGNANT PLEURAL MESOTHELIOMA, PLAQUE, NSCLC
Vaccinia virus was detectable by viral plaque assay in the pleural fluid of 7 patients (Results of viral plaque assay (pleural fluid).-Insufficient sample⬛Not performedADC, adenocarcinoma; MPM, malignant pleural mesothelioma; NSCLC, non-small cell lung cancer; PFU, plaque-forming units; SCC, squamous cell carcinoma; TNBC, triple negative breast cancer.Results of viral plaque assay (other specimens).⬛Not performedMPM, malignant pleural mesothelioma; PFU, plaque-forming units.Among 7 patients whose baseline serum was available to perform vaccinia virus neutralization assay, 4 patients had low levels of anti-vaccinia neutralizing antibodies pre-treatment, and 3 had no neutralizing antibodies (Results of vaccinia virus neutralization assay (serum).–Insufficient sampleADC, adenocarcinoma; MPM, malignant pleural mesothelioma; NSCLC, non-small cell lung cancer; PFU, plaque-forming units; SCC, squamous cell carcinoma; TNBC, triple negative breast cancer.